Morgan Stanley kicked off another large sale of X Corp debt, seizing on investors’ sudden embrace of the social media ...
Seeking Alpha on MSN3h
Adaptive Biotechnologies targets $1,300 ASP for MRD tests in 2025 driven by pricing improvementsCEO Chad Robins highlighted a strong year for Adaptive Biotechnologies, with MRD revenue increasing by 42% year-over-year. Key drivers included a higher gapfill rate of $2,007 for the clonoSEQ test ...
KeyBanc analyst Philip Gibbs maintained a Hold rating on United States Steel (X – Research Report) yesterday. The company’s shares closed ...
Catch up on the top artificial intelligence news and commentary by Wall Street analysts on publicly traded companies in the space with this ...
Investors faced further pain as India’s equity market extended its losing streak for the fifth consecutive session on Tuesday ...
The latest panic in domestic equities emerged after brokerages like Nomura and Morgan Stanley saw India to face the brunt of ...
Tesla shares fell 6% on Tuesday and have dropped for five straight days, wiping out over $200 billion in market cap.
Q2 2025 Management View CEO Michael Kliger highlighted that Mytheresa achieved strong revenue growth and significantly improved adjusted EBITDA in Q2 2025, continuing positive business momentum from ...
RBC Capital Markets adjusted its outlook on Edgewell Personal Care shares (NYSE:EPC), lowering the price target to $43.00 from the previous $48.00, while continuing to endorse the stock with an ...
IMPALA Platinum (Implats) said on Tuesday headline share earnings would be 40% to 49% weaker for the six months ended ...
The No. 14 Stony Brook women’s lacrosse team is ushering in a new era. In college athletics, great players and core groups ...
U.S. President Donald Trump loves tariffs and big numbers, so it's no surprise that the first targets in his trade war have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results